バイオバンキング市場：製品タイプ、サンプルタイプ、保管タイプ、用途、エンドユーザー別-2025～2030年世界予測

バイオバンキング市場は、2023年に703億3,000万米ドルと評価され、2024年には782億1,000万米ドルに達すると予測され、CAGR 11.71%で成長し、2030年には1,527億5,000万米ドルに達すると予測されています。

バイオバンキングは、研究と臨床治療用の生物学的サンプルの収集、処理、保管、管理を意味し、個別化医療、ゲノミクス、医薬品開発の推進に不可欠な役割を果たします。バイオバンキングの必要性は、バイオメディカル研究をサポートする高品質の生体材料の必要性が高まっていることから生じ、疾病の解明や治療法の革新において画期的な進歩を可能にします。その用途は、がん研究、遺伝子疾患研究、疫学など、さまざまな領域にわたります。エンドユーザーは学術研究機関から製薬会社、病院まで多岐にわたります。バイオバンキング市場に影響を与える主要成長要因には、慢性疾患の急増、再生医療の進歩、研究開発活動のための資金増加などがあります。精密医療の採用拡大がその重要性をさらに高めています。しかし、バイオバンキングは、厳しい規制要件、プライバシーや同意に関する倫理的懸念、サンプルの保管・保存技術における課題などの制約に直面しています。さらに、バイオバンク間のデータアクセスや相互運用性が制限されていることも、進歩の妨げとなっています。同市場における新たなビジネス機会としては、データ管理と解釈を強化するための人工知能とビッグデータ分析の統合が挙げられます。さらに、モバイルと分散型バイオバンキングアプローチの開発により、サンプルの多様性と代表性を広げることができます。ビジネス成長のための革新的なセグメントには、サンプル取り扱いのための標準化されたプロトコルの作成や、安全なデータ共有のためのブロックチェーンアプリケーションなどがあります。倫理的課題を克服し、バイオバンキングイニシアチブへの参加を促進するためには、コミュニティへの参加を改善し、社会的信頼を醸成することが引き続き重要です。バイオバンキング市場の性質は競争的でありながら協調的であり、バイオテクノロジー企業、学術機関、医療プロバイダー間のパートナーシップの機会があります。このセグメントに参入する企業は、新技術を効果的に活用するために、技術インフラの強化と戦略的提携の形成に注力すべきです。全体として、バイオバンキングは変革的医療ソリューションの最前線に位置し、研究とイノベーションはその可能性を引き出す上で極めて重要です。

市場力学：急速に進化するバイオバンキング市場の主要市場洞察を公開

バイオバンキング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 経済全体における慢性疾患の負担増と医療インフラ整備の必要性
  • 医薬品研究に対する民間と公的投資の増加
  • 再生医療に対する意識の高まりと政府の取り組み
• 市場抑制要因
  • バイオバンクの分散的性質による手順の調和に関連する問題
• 市場機会
  • バイオバンクにおけるデータ取得と分析の改善と標準化のための継続的研究
  • バイオバンクの持続可能性とイメージングバイオバンクの開発への注目の高まり
• 市場課題
  • バイオバンキングに関連する倫理的・法的懸念

ポーターのファイブフォース：バイオバンキング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオバンキング市場における外部からの影響の把握

外部マクロ環境要因は、バイオバンキング市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：バイオバンキング市場における競合情勢の把握

バイオバンキング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：バイオバンキング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオバンキング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：バイオバンキング市場における成功への道筋を描く

バイオバンキング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の負担が経済全体で増大し、医療インフラの改善が必要
    • 医薬品調査への民間と公的投資の増加
    • 再生医療に対する意識の高まりと政府の取り組み
  • 抑制要因
    • バイオバンクの分散化による手順の調和化に関連する問題
  • 機会
    • バイオバンクにおけるデータ収集と分析の標準化を改善し、確保するための継続的な研究
    • バイオバンクの持続可能性とイメージングバイオバンクの開発への注目の高まり
  • 課題
    • バイオバンキングに関連する倫理的と法的懸念
• 市場セグメンテーション分析
  • 製品：バイオバンキング操作を容易にするためのソフトウェア統合の拡大
  • サンプルタイプ：遺伝子研究における核酸サンプルの使用の増加
  • 保管タイプ：効率性と拡大性により、自動ストレージシステムが好まれる傾向が高まっている
  • エンドユーザー：医薬品開発のための製薬セグメントにおけるバイオバンクの拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 バイオバンキング市場：製品別

• イントロダクション
• 消耗品
• 設備と機器
• サービス
• ソフトウェア

第7章 バイオバンキング市場：サンプルタイプ別

• イントロダクション
• 体液
• 血液製品
• 細胞株
• ヒトの組織
• 核酸

第8章 バイオバンキング市場：保管タイプ別

• イントロダクション
• 自動
• 手動

第9章 バイオバンキング市場：用途別

• イントロダクション
• 臨床研究
• ライフサイエンス調査
• 再生医療

第10章 バイオバンキング市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 病院
• 製薬・バイオテクノロジー

第11章 南北アメリカのバイオバンキング市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のバイオバンキング市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのバイオバンキング市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • 新しいバイオバンキングパートナーシップにより、アメリカの絶滅危惧種の遺伝的多様性を保護
  • Crown Bioscience、Indivumedのサービス事業と支援バイオバンクを買収
  • CNIO biobankがEUから80万ユーロを受け取る
• 戦略分析と提言

企業一覧

• AMS BIoTechnology（Europe）Limited
• ASKION GmbH
• Avantor, Inc.
• Azenta Life Sciences
• Bay Biosciences LLC
• Becton, Dickinson and Company
• BioIVT LLC
• BioKryo by L'AIR LIQUIDE S.A.
• BocaBio
• Charles River Laboratories International, Inc.
• Cryoport Systems, LLC
• CTIBIoTech
• Cureline, Inc.
• Firalis Group
• Greiner AG
• Hamilton Company
• Merck KgaA
• Micronic Holding B.V.
• PHC Holdings Corporation
• Promega Corporation
• ProteoGenex
• QIAGEN N.V.
• Sopachem NV/SA
• SPT Labtech Ltd.
• STEMCELL Technologies Inc.
• Taylor-Wharton
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• UK Biobank Limited
• US Biolab Corporation, Inc.

LIST OF FIGURES

• FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
• FIGURE 2. BIOBANKING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOBANKING MARKET DYNAMICS
• TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 191. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023

The Biobanking Market was valued at USD 70.33 billion in 2023, expected to reach USD 78.21 billion in 2024, and is projected to grow at a CAGR of 11.71%, to USD 152.75 billion by 2030.

Biobanking refers to the collection, processing, storage, and management of biological samples for research and clinical care, playing an essential role in advancing personalized medicine, genomics, and drug development. The necessity of biobanking arises from the growing need for high-quality biomaterials to support biomedical research, enabling breakthroughs in disease understanding and therapeutic innovation. Its applications span across various domains, including cancer research, genetic disorder studies, and epidemiology. End-users range from academic and research institutions to pharmaceutical companies and hospitals. Key growth factors influencing the biobanking market include the surge in chronic disease prevalence, advancements in regenerative medicine, and increased funding for R&D activities. The expanding adoption of precision medicine further amplifies its importance. However, biobanking faces limitations such as stringent regulatory requirements, ethical concerns regarding privacy and consent, and challenges in sample storage and preservation technologies. Moreover, limited data access and interoperability between biobanks can impede progress. Emerging opportunities in the market include the integration of artificial intelligence and big data analytics to enhance data management and interpretation. Additionally, the development of mobile and decentralized biobanking approaches can broaden sample diversity and representation. Innovative areas for business growth include the creation of standardized protocols for sample handling and blockchain applications for secure data sharing. Improving community engagement and fostering public trust remain critical to overcoming ethical challenges and boosting participation in biobanking initiatives. The nature of the biobanking market is competitive yet collaborative, with opportunities for partnerships among biotechnology firms, academic institutions, and healthcare providers. Companies venturing into this space should focus on enhancing their technological infrastructure and forming strategic alliances to harness emerging technologies effectively. Overall, biobanking stands at the forefront of transformative healthcare solutions, with research and innovation being pivotal to unlocking its potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanking Market

The Biobanking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
  • Growing private and public investments in pharmaceutical research
  • Rising awareness and government initiatives in regenerative medicine
• Market Restraints
  • Problems associated with procedure harmonization due to decentralized nature of biobanks
• Market Opportunities
  • Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
  • Emerging focus on biobank sustainability and development of imaging biobanks
• Market Challenges
  • Ethical and legal concerns associated with biobanking

Porter's Five Forces: A Strategic Tool for Navigating the Biobanking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanking Market

A detailed market share analysis in the Biobanking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanking Market

A strategic analysis of the Biobanking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Market Segmentation & Coverage

This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software.
• Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
• Based on Storage Type, market is studied across Automated and Manual.
• Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
• Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
    • 5.1.1.2. Growing private and public investments in pharmaceutical research
    • 5.1.1.3. Rising awareness and government initiatives in regenerative medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
    • 5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical and legal concerns associated with biobanking
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding software integration to facilitate the biobanking operations
  • 5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
  • 5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
  • 5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biobanking Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment & Instruments
• 6.4. Services
• 6.5. Software

7. Biobanking Market, by Sample Type

• 7.1. Introduction
• 7.2. Biological Fluids
• 7.3. Blood Products
• 7.4. Cell Lines
• 7.5. Human Tissues
• 7.6. Nucleic Acids

8. Biobanking Market, by Storage Type

• 8.1. Introduction
• 8.2. Automated
• 8.3. Manual

9. Biobanking Market, by Application

• 9.1. Introduction
• 9.2. Clinical Research
• 9.3. Life Science Research
• 9.4. Regenerative Medicine

10. Biobanking Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Hospitals
• 10.4. Pharmaceutical & Biotechnology

11. Americas Biobanking Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Biobanking Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Biobanking Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
  • 14.3.2. Crown Bioscience to Acquire Indivumed's Service Business and Supporting Biobank
  • 14.3.3. CNIO biobank receives EUR 800,000 from the EU
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AMS Biotechnology (Europe) Limited
• 2. ASKION GmbH
• 3. Avantor, Inc.
• 4. Azenta Life Sciences
• 5. Bay Biosciences LLC
• 6. Becton, Dickinson and Company
• 7. BioIVT LLC
• 8. BioKryo by L'AIR LIQUIDE S.A.
• 9. BocaBio
• 10. Charles River Laboratories International, Inc.
• 11. Cryoport Systems, LLC
• 12. CTIBiotech
• 13. Cureline, Inc.
• 14. Firalis Group
• 15. Greiner AG
• 16. Hamilton Company
• 17. Merck KgaA
• 18. Micronic Holding B.V.
• 19. PHC Holdings Corporation
• 20. Promega Corporation
• 21. ProteoGenex
• 22. QIAGEN N.V.
• 23. Sopachem NV/SA
• 24. SPT Labtech Ltd.
• 25. STEMCELL Technologies Inc.
• 26. Taylor-Wharton
• 27. Tecan Trading AG
• 28. Thermo Fisher Scientific Inc.
• 29. UK Biobank Limited
• 30. US Biolab Corporation, Inc.